Effectiveness of administration of phenylbutazone alone or concurrent administration of phenylbutazone and flunixin meglumine to alleviate lameness in horses

American Journal of Veterinary Research

Volumn 69, Issue 2, 2008, Pages 167-173

  Keegan, Kevin G ^a   Messer, Nat T ^a   Reed, Shannon K ^a,b   Wilson, David A ^a   Kramer, Joanne ^a  

^a UNIVERSITY OF MISSOURI   (United States)

^b OREGON STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUNIXIN MEGLUMINE; PHENYLBUTAZONE;

ANIMAL EXPERIMENT; ANIMAL LAMENESS; ANIMAL MODEL; ARTICLE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DISEASE DURATION; DRUG BLOOD LEVEL; DRUG EFFICACY; EVENING DOSAGE; FEMALE; FORELIMB; HINDLIMB; HORSE DISEASE; KINEMATICS; MALE; MONOTHERAPY; MORNING DOSAGE; NONHUMAN; OSTEOARTHRITIS; TREADMILL ERGOMETRY;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CLONIXIN; CROSS-OVER STUDIES; DRUG THERAPY, COMBINATION; FEMALE; HORSE DISEASES; HORSES; LAMENESS, ANIMAL; MALE; PHENYLBUTAZONE;

ANIMALIA; EQUIDAE;

EID: 39549101426     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: 10.2460/ajvr.69.2.167     Document Type: Article

References (26)

1. United States Equestrian Federation (USEF). Drugs and Medications Guidelines. August 1, 2007. Available at: http//www.usef.org/documents/ competitions/2007/2007DrugsMedsGuidelines.pdf.
2. American Association of Equine Practitioners. Guide for veterinary service and judging of equestrian events. 4th ed. Lexington, Ky: American Association of Equine Practitioners, 1991.
3. Keegan KG, Pai PF, Wilson DA, et al. A curve-fitting technique for evaluating head movement to measure forelimb lameness in horses. Biomed Sci Instrum 2000;36:239-244.
4. Kramer J, Keegan KG, Kelmer G, et al. Objective determination of pelvic movement during hind limb lameness using a signal decomposition method and pelvic height differences. Am J Vet Res 2004;65:741-747.
5. Kelmer G, Keegan KG, Kramer J, et al. Computer-assisted kinematic evaluation of induced compensatory lameness in horses trotting on a treadmill. Am J Vet Res 2005;66;646-655.
6. Lees P, Higgins AJ. Clinical pharmacology and therapeutic uses of non-steroidal anti-inflammatory drugs in the horse. Equine Vet J 1985;17:83-96.
7. Semrad SD, Sams RA, Harris ON, et al. Effects of concurrent administration of phenylbutazone and flunixin meglumine on pharmacokinetic variables and in vitro generation of thromboxane B2 in mares. Am J Vet Res 1993;54:1901-1905.
8. Tobin T, Chay S, Kamerling S, et al. Phenylbutazone in the horse: a review. J Vet Pharmacol Ther 1986;9:1-25.
9. Chay S, Woods WE, Nugent T, et al. The pharmacology of nonsteroidal anti-inflammatory drugs in the horse: flunixin meglumine (Banamine). Equine Pract 1982;4:16-23.
10. Higgins AJ, Lees P, Taylor JB. Influence of phenylbutazone on eicosanoid levels in equine acute inflammatory exudates. Cornell Vet 1984;74:198-207.
11. Lees P, Higgins AJ. Flunixin inhibits prostaglandin E2 production in equine inflammation. Res Vet Sci 1984;37:347-349.
12. Lees P, Taylor JBO, Maitho TE, et al. Metabolism, excretion, pharmacokinetics and tissue residues of phenylbutazone in the horse. Cornell Vet 1987;77:192-211.
13. Lees P, Taylor JBO, Higgins AJ, et al, Phenylbutazone and oxyphertbutazone distribution into tissue fluids in the horse. J Vet Pharmacol Ther 1986;9:204-212.
14. Higgins AJ, Lees P, Taylor JBO, et al. Flunixin meglumine: quantitative determination in and effects on composition of equine inflammatory exudate. Br Vet J 1986;142:163-169.
15. Raekallio M, Taylor PM, Bennett RC. Preliminary investigations of pain and analgesia assessment in horses administered phenylbutazone or placebo after arthroscopic surgery. Vet Surg 1997;26:150-155.
16. Toutain PL, Autefage A, Legrand C, et al. Plasma concentrations and therapeutic efficacy of phenylbutazone and flunixin meglumine in the horse: pharmacolkinetic/pharmacodynamic modeling. J Vet Pharmacol Ther 1994;17:459-469.
17. Erkert RS, MacAllister CG, Payton ME, et al. Use of force plate analysis to compare the analgesic effects of intravenous administration of phenylbutazone and flunixin meglumine in horses with navicular syndrome. Am J Vet Res 2005;66:284-288.
18. Hu HH, MacAllister CG, Payton ME, et al. Evaluation of the analgesic effects of phenylbutazone administered at a high or low dosage in horses with chronic lameness. J Am Vet Med Assoc 2005;226:414-417.
19. Soma LR, Gallis DE, Davis WL, et al. Phenylbutazone kinetics and metabolite concentrations in the horse after five days of administration. Am J Vet Res 1983;44:2104-2109.
20. Maitho TE, Lees P, Taylor JB. Absorption and pharmacokinetics of phenylbutazone in Welsh Mountain ponies. J Vet Pharmacol Ther 1986;9:26-39.
21. Toutain PL, Lassourd V. Pharmacokinetic/pharmacodynamic approach to assess irrelevant plasma or urine drug concentrations in postcompetition samples for drug control in the horse. Equine Vet J 2002;34:242-249.
22. MacAllister CG, Morgan SJ, Borne AT, et al. Comparison of adverse effects of phenylbutazone, flunixin meglumine, and ketoprofen in horses. J Am Vet Med Assoc 1993;202:71-77.
23. Houdeshell JW, Hennessey PW. A new nonsteroidal anti-inflammatory analgesic for horses. J Equine Med Surg 1977; 1:57-63.
24. Carrick JB, Papich MG, Middleton DM, et al. Clinical and pathological effects of flunixin meglumine administration to neonatal foals. Can J Vet Res 1989;53:195-201.
25. Lees P, Creed CRS, Gerring EEL, et al. Biochemical and hematological effects of phenylbutazone in horses. Equine Vet J 1983;5:158-167.
26. Reed SK, Messer NT, Tessman RT, et al. Effects of phenylbutazone alone or in combination with flunixin meglumine on blood protein concentrations in horses. Am J Vet Res 2006;67:398-402.